Steps to Standardization and Validation of Hippocampal Volumetry as a Biomarker in Clinical Trials and Diagnostic Criterion for Alzheimer’s Disease

Alzheimer's and Dementia- United States

doi 10.1016/j.jalz.2011.04.007

Related search

Alzheimer’s Disease: Initial Clinical Implementation of Automated Volumetry

Canadian Journal of Neurological Sciences

English

Validation of Gene Expression Biomarker Analysis for Biopsy-Based Clinical Trials in Crohnʼs Disease

Inflammatory Bowel Diseases

Gastroenterology

English

Tau Imaging in Alzheimer’s Disease Diagnosis and Clinical Trials

Neurotherapeutics

English

Novel Blood Biomarkers That Correlate With Cognitive Performance and Hippocampal Volumetry: Potential for Early Diagnosis of Alzheimer’s Disease

Journal of Alzheimer's Disease

Clinical Psychology

English

Recruitment, Retention and Other Methodological Issues Related to Clinical Trials for Alzheimer’s Disease

Journal of Nutrition, Health and Aging

English

Electrochemical Detection of Plasma Immunoglobulin as a Biomarker for Alzheimer’s Disease

Instrumentation

Information Systems

Electronic Engineering

Analytical Chemistry

Molecular Physics,

English

Cystatin C in Newborns: A Promising Renal Biomarker in Search for Standardization and Validation

Journal of Maternal-Fetal and Neonatal Medicine

English

A Diagnostic Methodology for Alzheimer’s Disease

Journal of Clinical Bioinformatics

English

A Review of Drugs for Treatment of Alzheimer’s Disease in Clinical Trials: Main Trends

Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova

English